Investment in the sector must be selective. Grifols, Rovi and Faes will be the favorites in Spain. In Europe and the US, Sanofi, Roche, Pfizer and J&J are attractive.
The pharmaceutical sector has gone into the background in the year after the pandemic began, but it has rises this year and opportunities beyond Covid-19, just one after that Pfizer publish the high efficiency rates of its
To continue reading become Premium
Try it for € 1 the first month
and enjoy unlimited access to all Expansión web content
–
Already Premium? Beautify
–
–
– .
Related posts:
Regular Exercise May Reduce the Risk of Parkinson's Disease in Women, Study Finds.
Controversial AI-Generated Figures Rock Scientific Community and Damage Journal's Reputation
Taking care of the cancer patient, the 'Arianna' project is born in Ravenna
Breast cancer increasingly treatable Early detection can save lives
